Shareholders' Equity and Capital Stock (Details 4) $ in Thousands |
9 Months Ended |
|---|---|
|
Sep. 30, 2022
USD ($)
shares
| |
| Remaining Life (years) | 4 months 24 days |
| Aggregate Intrinsic Value | $ | $ 1,102,710 |
| Number Of Unvested Units | shares | 1,011,660 |
| November 13, 2022 [Member] | |
| Remaining Life (years) | 1 month 6 days |
| Aggregate Intrinsic Value | $ | $ 769,682 |
| Number Of Unvested Units | shares | 706,130 |
| Redemption Date | Nov. 13, 2022 |
| August 27, 2023 [Member] | |
| Remaining Life (years) | 10 months 24 days |
| Aggregate Intrinsic Value | $ | $ 333,028 |
| Number Of Unvested Units | shares | 305,530 |
| Redemption Date | Aug. 27, 2023 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|